>There’s no answers, just more intelligent and informed questions, but here’s an interesting discussion on “Money Driven Medicine” at the blog, Marginal Revolution. One of the blog owners, Tyler Cowen, has a piece in the business section of today’s New York Times, “Enter the Neuro-economists: Why do investors do what they do?:
Washington State is planning to offer the Human Papilloma Virus vaccine free to girls. New Hampshire has made the vaccine available on an “opt in” basis. Florida’s Legislators are considering following Texas Governor Rick Perry in making the vaccine mandatory, with an “opt out” option, similar to the way that Hepatitis B and other mandated … Continue reading
That’ll shock ’em on the coasts, won’t it? Not to mention France and England, since the story has gone global. Governor Rick Perry reportedly (free registration required) has signed an order mandating that teen girls in the State of Texas receive the vaccine against four strains of the Human Papilloma Virus by 12 years old … Continue reading
The UT Austin Daily Texan has the only report that I can find in the news about Wednesday’s announcement that the University of Texas Health Center in Houston is the recipient of $17.9 million for stem cell research on treatments for heart disease. The National Heart Lung and Blood Institute granted $17.9 million for the … Continue reading
>Opexa is a division of Pharmafronteirs (or it’s the other way around, I’m not sure) which is based at the Woodlands, near Houston, Texas. The company specializes in cell therapies, based on adult stem cells and the controlled manipulation and replication of adult cells. Multiple sclerosis (MS)is a disease that causes the loss of the … Continue reading
>Pluristem is one of the companies focusing on the commercial development of stem cells. There are two or three names which have been regularly sending out press releases concerning their research and development (besides ACT, of course). In this case, it’s a company that’s marketing selected umbilical cord blood cells or placental cells. If the … Continue reading
>Since Mr. Reed has urged us to follow the money trail, and after my talk with the banker last week, I was pleased to see that others are looking at ethical stem cells as an investment. The business journal, Bloomberg, reported on several companies that are involved in ethical stem cell research. Evidently, these companies … Continue reading
“Pay for Performance” (P4P, sometimes called “Pay for Play” by some of us who aren’t fond of the scheme) just got a huge boost from Congress. Expect to see more docs carrying computers equipped to run an “electronic medical record” (EMR) around the office. And don’t be surprised to see more solo and small group … Continue reading
The “Texas Insider” email newsletter gives us a “scoop” about funding for the Patient Navigator, Navigators are specially trained individuals who answer patients’ questions and allay their fears about diagnosis, treatment and insurance coverage. The program is modeled after successful initiatives such as the Harlem Navigator Program in New York City and the Washington Hospital … Continue reading
One more reason I do not want government-only healthcare. According to the “Medicare Learning News,” (a pdf document) no payments will be made to Medicare “providers” (doctors, hospitals, pharmacies, and the intermediate insurance companies with which the government contracts to “manage” Medicare) for the last 9 days of the fiscal year, September 22 to September … Continue reading